NO924912L - Fremgangsmaate ved paavisning av analyttvarianter, samt sett for utfoerelse av fremgangsmaaten - Google Patents

Fremgangsmaate ved paavisning av analyttvarianter, samt sett for utfoerelse av fremgangsmaaten

Info

Publication number
NO924912L
NO924912L NO92924912A NO924912A NO924912L NO 924912 L NO924912 L NO 924912L NO 92924912 A NO92924912 A NO 92924912A NO 924912 A NO924912 A NO 924912A NO 924912 L NO924912 L NO 924912L
Authority
NO
Norway
Prior art keywords
variants
population
pct
procedure
fractionation system
Prior art date
Application number
NO92924912A
Other languages
English (en)
Other versions
NO924912D0 (no
NO303852B1 (no
Inventor
Erling Sundrehagen
Original Assignee
Axis Research
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26297237&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO924912(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB909013895A external-priority patent/GB9013895D0/en
Priority claimed from GB919102024A external-priority patent/GB9102024D0/en
Application filed by Axis Research filed Critical Axis Research
Publication of NO924912D0 publication Critical patent/NO924912D0/no
Publication of NO924912L publication Critical patent/NO924912L/no
Publication of NO303852B1 publication Critical patent/NO303852B1/no

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803General methods of protein analysis not limited to specific proteins or families of proteins
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/537Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody
    • G01N33/538Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody by sorbent column, particles or resin strip, i.e. sorbent materials
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/79Transferrins, e.g. lactoferrins, ovotransferrins
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/964Chemistry: molecular biology and microbiology including enzyme-ligand conjugate production, e.g. reducing rate of nonproductive linkage
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/975Kit
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/807Apparatus included in process claim, e.g. physical support structures
    • Y10S436/808Automated or kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
  • Devices For Executing Special Programs (AREA)
  • Apparatus For Radiation Diagnosis (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
NO924912A 1990-06-21 1992-12-18 FremgangsmÕte ved pÕvisning av analyttvarianter, samt sett for utf°relse av fremgangsmÕten NO303852B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB909013895A GB9013895D0 (en) 1990-06-21 1990-06-21 Analyte variant analysis
GB919102024A GB9102024D0 (en) 1991-01-30 1991-01-30 Analyte variant analysis
PCT/EP1991/001145 WO1991019983A1 (en) 1990-06-21 1991-06-20 Analyte variant analysis

Publications (3)

Publication Number Publication Date
NO924912D0 NO924912D0 (no) 1992-12-18
NO924912L true NO924912L (no) 1993-02-22
NO303852B1 NO303852B1 (no) 1998-09-07

Family

ID=26297237

Family Applications (1)

Application Number Title Priority Date Filing Date
NO924912A NO303852B1 (no) 1990-06-21 1992-12-18 FremgangsmÕte ved pÕvisning av analyttvarianter, samt sett for utf°relse av fremgangsmÕten

Country Status (15)

Country Link
US (1) US5352616A (no)
EP (1) EP0535162B1 (no)
JP (1) JP2517187B2 (no)
AT (1) ATE120551T1 (no)
AU (1) AU654497B2 (no)
CA (1) CA2085579A1 (no)
CZ (1) CZ283072B6 (no)
DE (1) DE69108554T2 (no)
DK (1) DK0535162T3 (no)
ES (1) ES2069902T3 (no)
FI (1) FI925781A0 (no)
HU (1) HU215555B (no)
NO (1) NO303852B1 (no)
SK (1) SK279009B6 (no)
WO (1) WO1991019983A1 (no)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69229230T2 (de) * 1991-09-25 2000-01-27 Samar Makhlouf Antikörpertest zur erkennung von alkoholikern und zur überwachung der alkoholaufnahme
US5843680A (en) * 1992-01-31 1998-12-01 Biometric Imaging, Inc. Differential separation assay methods and test kits
US5571729A (en) * 1992-06-17 1996-11-05 Wako Pure Chemical Industries, Ltd. Process for separating complex
SE501668C2 (sv) * 1993-08-06 1995-04-10 Biolin Medical Ab Kvantifiering av CD-transferrin vid hög alkoholkonsumtion med HPLC
DE4447334B4 (de) * 1994-12-31 2004-01-15 Karin Artelt-Zerfass Behandlungsgerät für medizinische und/oder therapeutische Anwendungen
DE69622278T2 (de) * 1995-02-22 2003-04-03 Axis Shield Asa Oslo CDT Test
US5798212A (en) * 1995-02-22 1998-08-25 Axis Biochemicals Asa CDT assay
CA2181109A1 (en) * 1995-07-18 1997-01-19 Nobuko Imajo Polypeptide and process for measuring living body components using the same
DE19543569C2 (de) * 1995-11-22 1998-01-22 Atou Lo Verwendung des Lectins Sambucus nigra zur Quantifizierung der endständigen Sialinsäurereste des Human-Transferrin-Moleküls mittels einer vollimmunoenzymatischen Methode (EIA)
SE9602234D0 (sv) * 1996-06-06 1996-06-06 Pharmacia Ab A novel diagnostic method utilizing ECP, and reagents to be used in the methods
EP1002232A4 (en) 1997-07-15 2004-05-26 Bioprobes Inc DETERMINATION OF ALCOHOL CONSUMPTION USING SIALIC ACID / APO J
GB9827411D0 (en) * 1998-12-11 1999-02-03 Axis Biochemicals Asa Dipstick assay
GB9929308D0 (en) * 1999-12-10 2000-02-02 Axis Shield Plc Assay
US6255047B1 (en) * 2000-02-28 2001-07-03 Bio-Rad Laboratories, Inc. Biosynthetic carbohydrate-deficient transferrin references
AR040711A1 (es) * 2002-07-29 2005-04-13 Us Agriculture Un metodo para verificacion de calidad/control de calidad para proceso de bioensayo de alto rendimiento
US7691640B2 (en) * 2005-09-30 2010-04-06 Adeline Vanderver Biochemical marker for diagnosing a leukodystrophy
TW202346856A (zh) * 2022-03-18 2023-12-01 美商里珍納龍藥品有限公司 分析多肽變體的方法及系統

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4338396A (en) * 1976-10-06 1982-07-06 Kiyasu John Y Heart attack screening method and process
JPS59126246A (ja) * 1983-01-08 1984-07-20 Fuji Photo Film Co Ltd Dnaもしくはdna部分分解物の塩基配列決定方法
SE440699B (sv) * 1984-02-06 1985-08-12 Pharmacia Ab Sett att medelst isotransferrinbestemning uppskatta en individs alkoholkonsumtion
JPH07113606B2 (ja) * 1986-10-27 1995-12-06 株式会社島津製作所 塩基配列決定装置
JPS6388747U (no) * 1986-11-28 1988-06-09
JP2594925B2 (ja) * 1987-01-23 1997-03-26 株式会社日立製作所 電気泳動装置
CA1320114C (en) * 1987-05-12 1993-07-13 Frank J. Lucas Method and test kit for neutralization/immunoinhibition assay
AU626563B2 (en) * 1988-01-29 1992-08-06 Abbott Laboratories Ion-capture reagents and methods for performing binding assays
JP2686565B2 (ja) * 1989-12-25 1997-12-08 忠三 岸本 C/ebp2遺伝子及びリコンビナントc/ebp2

Also Published As

Publication number Publication date
EP0535162B1 (en) 1995-03-29
AU654497B2 (en) 1994-11-10
NO924912D0 (no) 1992-12-18
DE69108554D1 (de) 1995-05-04
SK279009B6 (sk) 1998-05-06
WO1991019983A1 (en) 1991-12-26
AU8322891A (en) 1992-01-07
ATE120551T1 (de) 1995-04-15
FI925781A (fi) 1992-12-18
DE69108554T2 (de) 1995-08-31
EP0535162A1 (en) 1993-04-07
ES2069902T3 (es) 1995-05-16
JP2517187B2 (ja) 1996-07-24
FI925781A0 (fi) 1992-12-18
CA2085579A1 (en) 1991-12-22
NO303852B1 (no) 1998-09-07
CZ283072B6 (cs) 1997-12-17
CZ374392A3 (en) 1993-05-12
JPH06502912A (ja) 1994-03-31
US5352616A (en) 1994-10-04
HU9204073D0 (en) 1993-04-28
DK0535162T3 (da) 1995-06-12
SK374392A3 (en) 1995-05-10
HU215555B (hu) 1999-01-28
HUT65621A (en) 1994-07-28

Similar Documents

Publication Publication Date Title
NO924912L (no) Fremgangsmaate ved paavisning av analyttvarianter, samt sett for utfoerelse av fremgangsmaaten
SE9504046D0 (sv) Method of determining affinity and kinetic properties
DE69429192D1 (de) Ein verfahren zur bestimmung von kollagenfragmenten in körperflüssigkeiten, ein testkit und mittel zur durchführung des verfahrens, und seine verwendung zur feststellung von mit dem kollagenmetabolismus assoziierten störungen
ATE58600T1 (de) Testverfahren.
DE3669206D1 (de) Verfahren zur quantifizierung von zellpopulationen bzw. subpopulationen sowie hierfuer geeignetes reagenz.
DE60019111D1 (de) Verfahren zur zellseparation unter verwendung von immunorosetten
DE69519160D1 (de) Verfahren zur quantitativen analyse von cholesterin
DK622688A (da) Analysemetode og testsystem til bestemmelse af en analyt i en blodproeve
MX164526B (es) Muestra de ensayo irradiada con particulas metalicas dispersas
DK314987A (da) Fremgangsmaade til specifik bestemmelse af serumfructosaminindhold samt hertil egnet reagensblanding
ES2118062T3 (es) Composiciones reactivas, metodos y reactivos para la valoracion cuantitativa de magnesio o de calcio y magnesio.
DE69214906T2 (de) Homogene Immunotests unter Verwendung von Enzym-Inhibitoren
SE8304145D0 (sv) Antigenanalysmetod och set
NO963477L (no) Analysekuvette, fremgangsmåte samt diagnostisk sett for bestemmelse av analytter i fullblod-pröver
AU7110796A (en) Borate storage buffer and sample diluent
DK0402997T3 (da) Fremgangsmåde til bestemmelse af nukleinsyre
DE60028190D1 (de) Verfahren zur quantifizierung von cholesterin
DE3850346T2 (de) Verfahren zur Selbstdurchführung von Enzymkinetik.
ATE208505T1 (de) Verfahren und reagenz zur überwachung des blutspiegels von antiplättchen-verbindungen
IL124093A (en) Cyanide containing hemoglobin reagent composition and method for the determination of hemoglobin in blood

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN DECEMBER 2000